tobramycin has been researched along with acetylglucosamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beauchamp, D; Bergeron, MG; Bergeron, Y; Grenier, L; Labrecque, G; Lin, L; Simard, M | 1 |
| Baker, SM; Giatpaiboon, S; LiPuma, JJ; Narayanaswamy, VP; Townsend, SM; Wiesmann, WP | 1 |
2 other study(ies) available for tobramycin and acetylglucosamine
| Article | Year |
|---|---|
Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in rats.
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Body Weight; Female; Immunohistochemistry; Kidney Cortex; Kidney Diseases; Rats; Rats, Sprague-Dawley; Subcellular Fractions; Thymidine; Time Factors; Tobramycin | 1994 |
Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem.
Topics: Acetylglucosamine; Anti-Bacterial Agents; Burkholderia cepacia complex; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Meropenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 2017 |